<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercebiotech.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Thomas Harlan</title>
 <link>http://www.fiercebiotech.com/tags/thomas-harlan</link>
 <description></description>
 <language>en</language>
<item>
 <title>Emergent adds new space for biotech start-ups</title>
 <link>http://www.fiercebiotech.com/story/eti-adds-new-space-biotech-start-ups/2008-06-16?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;Emergent Technologies (ETI)&amp;nbsp;has doubled its office space, taking new digs in Austin that includes new laboratory space for the biotech companies that it helps foster. ETI specializes in creating new companies that are engaged in commercializing research pioneered at regional universities.&lt;/p&gt;
&lt;p&gt;Thomas Harlan, president and CEO of ETI, told the &lt;em&gt;Austin Business Journal&lt;/em&gt; that the company had just run out of room. ETI moved from 12,000 square feet into 23,000 square feet of space. ETI closed a $27 million fund in the spring of 2007 and used the money to launch three companies: Mimetic Solutions, Beacon Sciences and AeonClad Coatings.&lt;/p&gt;
&lt;p&gt;&quot;The biotech sector is a limitless one,&quot; Harlan told the newspaper. &quot;We&#039;re delighted to be sitting in a region where there&#039;s abundant deal flow, in terms of the science coming from the university.&quot;&lt;/p&gt;
&lt;p&gt;- read the &lt;a href=&quot;http://austin.bizjournals.com/austin/stories/2008/01/14/story4.html&quot;&gt;report&lt;/a&gt; in the &lt;em&gt;Austin Business Journal&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Related Articles:&lt;br /&gt;&lt;/strong&gt;&lt;a href=&quot;http://www.fiercebiotech.com/story/emergent-biosolutions-buys-flu-vaccine-maker/2008-05-27&quot;&gt;Emergent BioSolutions buys flu vaccine maker&lt;/a&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fiercebiotech.com/story/emergent-biosolutions-files-86m-ipo/2006-08-15&quot;&gt;Emergent BioSolutions files $86M IPO&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.fiercebiotech.com/story/eti-adds-new-space-biotech-start-ups/2008-06-16#comments</comments>
 <category domain="http://www.fiercebiotech.com/tags/share-price">Biotech IPO</category>
 <category domain="http://www.fiercebiotech.com/tags/emergent-biosolutions-0">Emergent BioSolutions</category>
 <category domain="http://www.fiercebiotech.com/tags/flu-season">flu</category>
 <category domain="http://www.fiercebiotech.com/tags/flu-vaccine">flu vaccine</category>
 <category domain="http://www.fiercebiotech.com/tags/science">science</category>
 <category domain="http://www.fiercebiotech.com/tags/thomas-harlan">Thomas Harlan</category>
 <pubDate>Mon, 16 Jun 2008 07:24:42 -0400</pubDate>
 <dc:creator>John Carroll</dc:creator>
 <guid isPermaLink="false">28602 at http://www.fiercebiotech.com</guid>
</item>
</channel>
</rss>
